SECURITIES & EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
(Rule 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b), (c) AND (d) AND AMENDMENTS THERETO FILED
PURSUANT TO RULE 13d-2
(Amendment No. _)*
Arcturus Therapeutics Holdings Inc
(Name of Issuer)
Common Stock
(Title of Class of Securities)
03969T109
(CUSIP Number)
September 1, 2020
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
| ¨ | Rule 13d-1(b) |
| x | Rule 13d-1(c) |
| ¨ | Rule 13d-1(d) |
(Page 1 of 17 Pages)
*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
| CUSIP No. 03969T109 | 13G | Page 2 of 17 Pages |
| (1) | NAMES OF REPORTING PERSONS
|
|
| (2) | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) ¨ |
|
| (3) | SEC USE ONLY |
|
| (4) | CITIZENSHIP OR PLACE OF ORGANIZATION Delaware |
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
(5) | SOLE VOTING POWER 0 |
| (6) | SHARED VOTING POWER 1,584,466 | |
| (7) | SOLE
DISPOSITIVE POWER 0 | |
| (8) | SHARED DISPOSITIVE POWER 1,584,466 |
| (9) | AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,584,466 |
|
| (10) | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (see instructions) |
¨ |
| (11) | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 6.5% |
|
| (12) | TYPE OF REPORTING PERSON (see instructions) PN |
| CUSIP No. 03969T109 | 13G | Page 3 of 17 Pages |
| (1) | NAMES
OF REPORTING PERSONS
|
|
| (2) | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) ¨ |
|
| (3) | SEC USE ONLY |
|
| (4) | CITIZENSHIP OR PLACE OF ORGANIZATION Delaware |
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
(5) | SOLE VOTING POWER 0 |
| (6) | SHARED VOTING POWER 1,584,466 | |
| (7) | SOLE
DISPOSITIVE POWER 0 | |
| (8) | SHARED DISPOSITIVE POWER 1,584,466 |
| (9) | AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,584,466 |
|
| (10) | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (see instructions) |
¨ |
| (11) | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 6.5% |
|
| (12) | TYPE OF REPORTING PERSON (see instructions) OO - limited liability company |
| CUSIP No. 03969T109 | 13G | Page 4 of 17 Pages |
| (1) | NAMES
OF REPORTING PERSONS
|
|
| (2) | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) ¨ |
|
| (3) | SEC USE ONLY |
|
| (4) | CITIZENSHIP OR PLACE OF ORGANIZATION Cayman Islands |
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
(5) | SOLE VOTING POWER 0 |
| (6) | SHARED
VOTING POWER 292,705 | |
| (7) | SOLE
DISPOSITIVE POWER 0 | |
| (8) | SHARED
DISPOSITIVE POWER 292,705 |
| (9) | AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 292,705 |
|
| (10) | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (see instructions) |
¨ |
| (11) | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 1.2% |
|
| (12) | TYPE
OF REPORTING PERSON (see instructions) PN |
| CUSIP No. 03969T109 | 13G | Page 5 of 17 Pages |
| (1) | NAMES
OF REPORTING PERSONS
|
|
| (2) | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) ¨ |
|
| (3) | SEC USE ONLY |
|
| (4) | CITIZENSHIP OR PLACE OF ORGANIZATION Delaware |
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
(5) | SOLE VOTING POWER 0 |
| (6) | SHARED
VOTING POWER 292,705 | |
| (7) | SOLE
DISPOSITIVE POWER 0 | |
| (8) | SHARED
DISPOSITIVE POWER 292,705 |
| (9) | AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 292,705 |
|
| (10) | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (see instructions) |
¨ |
| (11) | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 1.2% |
|
| (12) | TYPE
OF REPORTING PERSON (see instructions) OO – limited liability company |
| CUSIP No. 03969T109 | 13G | Page 6 of 17 Pages |
| (1) | NAMES
OF REPORTING PERSONS
|
|
| (2) | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) ¨ |
|
| (3) | SEC USE ONLY |
|
| (4) | CITIZENSHIP OR PLACE OF ORGANIZATION Delaware |
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
(5) | SOLE VOTING POWER 0 |
| (6) | SHARED
VOTING POWER 830,270 | |
| (7) | SOLE
DISPOSITIVE POWER 0 | |
| (8) | SHARED
DISPOSITIVE POWER 830,270 |
| (9) | AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 830,270 |
|
| (10) | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (see instructions) |
¨ |
| (11) | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 3.4% |
|
| (12) | TYPE
OF REPORTING PERSON (see instructions) OO – limited liability company |
| CUSIP No. 03969T109 | 13G | Page 7 of 17 Pages |
| (1) | NAMES
OF REPORTING PERSONS
|
|
| (2) | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) ¨ |
|
| (3) | SEC USE ONLY |
|
| (4) | CITIZENSHIP OR PLACE OF ORGANIZATION United States |
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
(5) | SOLE VOTING POWER 0 |
| (6) | SHARED
VOTING POWER 1,584,466 | |
| (7) | SOLE
DISPOSITIVE POWER 0 | |
| (8) | SHARED
DISPOSITIVE POWER 1,584,466 |
| (9) | AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,584,466 |
|
| (10) | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (see instructions) |
¨ |
| (11) | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 6.5% |
|
| (12) | TYPE
OF REPORTING PERSON (see instructions) IN |
| CUSIP No. 03969T109 | 13G | Page 8 of 17 Pages |
| (1) | NAMES
OF REPORTING PERSONS
|
|
| (2) | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) ¨ |
|
| (3) | SEC USE ONLY |
|
| (4) | CITIZENSHIP OR PLACE OF ORGANIZATION United States |
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
(5) | SOLE VOTING POWER 0 |
| (6) | SHARED
VOTING POWER 1,584,466 | |
| (7) | SOLE
DISPOSITIVE POWER 0 | |
| (8) | SHARED
DISPOSITIVE POWER 1,584,466 |
| (9) | AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,584,466 |
|
| (10) | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (see instructions) |
¨ |
| (11) | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 6.5% |
|
| (12) | TYPE
OF REPORTING PERSON (see instructions) IN |
| CUSIP No. 03969T109 | 13G | Page 9 of 17 Pages |
| (1) | NAMES
OF REPORTING PERSONS
|
|
| (2) | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) ¨ |
|
| (3) | SEC USE ONLY |
|
| (4) | CITIZENSHIP OR PLACE OF ORGANIZATION Cayman Islands |
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
(5) | SOLE VOTING POWER 0 |
| (6) | SHARED
VOTING POWER 447,395 | |
| (7) | SOLE
DISPOSITIVE POWER 0 | |
| (8) | SHARED
DISPOSITIVE POWER 447,395 |
| (9) | AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 447,395 |
|
| (10) | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (see instructions) |
¨ |
| (11) | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 1.8% |
|
| (12) | TYPE
OF REPORTING PERSON (see instructions) PN |
| CUSIP No. 03969T109 | 13G | Page 10 of 17 Pages |
| (1) | NAMES
OF REPORTING PERSONS
|
|
| (2) | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) ¨ |
|
| (3) | SEC USE ONLY |
|
| (4) | CITIZENSHIP OR PLACE OF ORGANIZATION Delaware |
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
(5) | SOLE VOTING POWER 0 |
| (6) | SHARED
VOTING POWER 447,395 | |
| (7) | SOLE
DISPOSITIVE POWER 0 | |
| (8) | SHARED
DISPOSITIVE POWER 447,395 |
| (9) | AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 447,395 |
|
| (10) | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (see instructions) |
¨ |
| (11) | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 1.8% |
|
| (12) | TYPE
OF REPORTING PERSON (see instructions) OO - limited liability company |
| CUSIP No. 03969T109 | 13G | Page 11 of 17 Pages |
| (1) | NAMES
OF REPORTING PERSONS
|
|
| (2) | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) ¨ |
|
| (3) | SEC USE ONLY |
|
| (4) | CITIZENSHIP OR PLACE OF ORGANIZATION Cayman Islands |
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
(5) | SOLE VOTING POWER 0 |
| (6) | SHARED
VOTING POWER 90,170 | |
| (7) | SOLE
DISPOSITIVE POWER 0 | |
| (8) | SHARED
DISPOSITIVE POWER 90,170 |
| (9) | AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 90,170 |
|
| (10) | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (see instructions) |
¨ |
| (11) | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 0.4% |
|
| (12) | TYPE
OF REPORTING PERSON (see instructions) PN |
| CUSIP No. 03969T109 | 13G | Page 12 of 17 Pages |
| (1) | NAMES
OF REPORTING PERSONS
|
|
| (2) | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) ¨ |
|
| (3) | SEC USE ONLY |
|
| (4) | CITIZENSHIP OR PLACE OF ORGANIZATION Delaware |
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
(5) | SOLE VOTING POWER 0 |
| (6) | SHARED
VOTING POWER 90,170 | |
| (7) | SOLE
DISPOSITIVE POWER 0 | |
| (8) | SHARED
DISPOSITIVE POWER 90,170 |
| (9) | AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 90,170 |
|
| (10) | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES (see instructions) |
¨ |
| (11) | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 0.4% |
|
| (12) | TYPE
OF REPORTING PERSON (see instructions) OO - limited liability company |
| CUSIP No. 03969T109 | 13G | Page 13 of 17 Pages |
| Item 1(a). | Name of Issuer: |
Arcturus Therapeutics Holdings Inc.
| Item 1(b). | Address of Issuer's Principal Executive Offices: |
10628 Science Center Drive, Suite 250, San Diego, California 92121
| Item 2(a, b, c). | Name of Person Filing: |
(i) HealthCor Management, L.P., a Delaware limited partnership, 55 Hudson Yards, 28th Floor, New York, NY 10001;
(ii) HealthCor Associates, LLC, a Delaware limited liability company, 55 Hudson Yards, 28th Floor, New York, NY 10001;
(iii) HealthCor Offshore Master Fund, L.P., a Cayman Islands limited partnership, 55 Hudson Yards, 28th Floor, New York, NY 10001;
(iv) HealthCor Offshore GP, LLC, a Delaware limited liability company, 55 Hudson Yards, 28th Floor, New York, NY 10001;
(v) HealthCor Group, LLC, a Delaware limited liability company, 55 Hudson Yards, 28th Floor, New York, NY 10001;
(vi) Joseph Healey, 55 Hudson Yards, 28th Floor, New York, NY 10001;
(vii) Arthur Cohen, 12 South Main Street, #203 Norwalk, CT 06854;
(viii) HealthCor Sanatate Offshore Master Fund, L.P., a Cayman Islands limited partnership, 55 Hudson Yards, 28th Floor, New York, NY 10001;
(ix) HealthCor Offshore II GP, LLC, a Delaware limited liability company, 55 Hudson Yards, 28th Floor, New York, NY 10001;
(x) HealthCor Therapeutics Master Fund, L.P., a Cayman Islands limited partnership, 55 Hudson Yards, 28th Floor, New York, NY 10001; and
(xi) HealthCor Therapeutics GP, LLC, a Delaware limited liability company, 55 Hudson Yards, 28th Floor, New York, NY 10001.
Both Mr. Healey and Mr. Cohen are United States citizens.
The persons at (i) through (xi) above are collectively referred to herein as the "Reporting Persons".
| CUSIP No. 03969T109 | 13G | Page 14 of 17 Pages |
| Item 2(d). | Title of Class of Securities: Common Stock (the "Common Stock") |
| Item 2(e). | CUSIP Number: 03969T109 |
| Item 3. | Not applicable. |
| Item 4. | Ownership. |
The information required by Items 4(a) - (c) is set forth in Rows 5 - 11 of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person.
Collectively, HealthCor Offshore Master Fund, L.P., HealthCor Sanatate Offshore Master Fund, L.P. and HealthCor Therapeutics Master Fund, L.P. (each a "Fund" and together, the "Funds") are the beneficial owners of a total of 830,270 shares of the Common Stock of the Issuer. In addition, HealthCor Management, L.P. manages separately managed accounts that collectively hold a total of 754,196 shares of the Common Stock of the Issuer.
HealthCor Offshore GP, LLC is the general partner of HealthCor Offshore Master Fund, L.P. Accordingly, HealthCor Offshore GP, LLC may be deemed to beneficially own the shares of Common Stock that are beneficially owned by HealthCor Offshore Master Fund, L.P. HealthCor Group, LLC is the managing member of HealthCor Offshore GP, LLC and, therefore, may be deemed to beneficially own the shares of Common Stock that are beneficially owned by HealthCor Offshore Master Fund, L.P.
HealthCor Offshore II GP, LLC is the general partner of HealthCor Sanatate Offshore Master Fund, L.P. Accordingly, HealthCor Offshore II GP, LLC may be deemed to beneficially own the shares of Common Stock that are beneficially owned by HealthCor Sanatate Offshore Master Fund, L.P. HealthCor Group, LLC is the managing member of HealthCor Offshore II GP, LLC and, therefore, may be deemed to beneficially own the shares of Common Stock that are beneficially owned by HealthCor Sanatate Offshore Master Fund, L.P.
HealthCor Therapeutics GP, LLC is the general partner of HealthCor Therapeutics Master Fund, L.P. Accordingly, HealthCor Therapeutics GP, LLC may be deemed to beneficially own the shares of Common Stock that are beneficially owned by HealthCor Therapeutics Master Fund, L.P. HealthCor Group, LLC is the managing member of HealthCor Therapeutics GP, LLC and, therefore, may be deemed to beneficially own the shares of Common Stock that are beneficially owned by HealthCor Therapeutics Master Fund, L.P.
| CUSIP No. 03969T109 | 13G | Page 15 of 17 Pages |
By virtue of its position as the investment manager of the Funds, HealthCor Management, L.P. may be deemed a beneficial owner of all the shares of Common Stock owned by the Funds, as well as those it manages through separately managed accounts. HealthCor Associates, LLC is the general partner of HealthCor Management, L.P. and thus may also be deemed to beneficially own the shares of Common Stock that are beneficially owned by HealthCor Management, L.P.
As the Managers of HealthCor Associates, LLC, Arthur Cohen and Joseph Healey exercise both voting and investment power with respect to the shares of Common Stock reported herein, and therefore each may be deemed a beneficial owner of such Common Stock.
Each of the Reporting Persons hereby disclaims any beneficial ownership of any such shares of Common Stock in excess of their actual pecuniary interest therein.
| Item 5. | Ownership of Five Percent or Less of a Class: |
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following [ ].
| Item 6. | Ownership of More than Five Percent on Behalf of Another Person. |
Not Applicable
| Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. |
Not Applicable
| Item 8. | Identification and Classification of Members of the Group. |
See Exhibit I.
| Item 9. | Notice of Dissolution of Group. |
Not Applicable
| Item 10. | Certification. |
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
Exhibits:
| Exhibit I: | Joint Acquisition Statement |
| CUSIP No. 03969T109 | 13G | Page 16 of 17 Pages |
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
DATED: September 11, 2020
| HEALTHCOR MANAGEMENT, L.P. | |||
| By: | HealthCor Associates, LLC, its general partner | ||
| /s/ Anabelle P. Gray | |||
| Name: | Anabelle P. Gray | ||
| Title: | General Counsel | ||
| HEALTHCOR OFFSHORE GP, LLC, for itself and as general partner of behalf of HEALTHCOR OFFSHORE MASTER FUND, L.P. | |||
| By: | HealthCor Group, LLC, its general partner | ||
| /s/ Anabelle P. Gray | |||
| Name: | Anabelle P. Gray | ||
| Title: | General Counsel | ||
| CUSIP No. 03969T109 | 13G | Page 17 of 17 Pages |
| HEALTHCOR OFFSHORE II GP, LLC, for itself and as general partner of behalf of HEALTHCOR SANATATE OFFSHORE MASTER FUND, L.P. | |||
| By: | HealthCor Group, LLC, its general partner | ||
| /s/ Anabelle P. Gray | |||
| Name: | Anabelle P. Gray | ||
| Title: | General Counsel | ||
| HEALTHCOR THERAPEUTICS GP, LLC, for itself and as general partner of behalf of HEALTHCOR THERAPEUTICS MASTER FUND, L.P. | |||
| By: | HealthCor Group, LLC, its general partner | ||
| /s/ Anabelle P. Gray | |||
| Name: | Anabelle P. Gray | ||
| Title: | General Counsel | ||
| HEALTHCOR ASSOCIATES, LLC | |||
| /s/ Anabelle P. Gray | |||
| Name: | Anabelle P. Gray | ||
| Title: | General Counsel | ||
| HEALTHCOR GROUP, LLC | |||
| /s/ Anabelle P. Gray | |||
| Name: | Anabelle P. Gray | ||
| Title: | General Counsel | ||
| JOSEPH HEALEY, Individually | |||
| /s/ Joseph Healey | |||
| ARTHUR COHEN, Individually | |||
| /s/ Arthur Cohen | |||
EXHIBIT I
JOINT ACQUISITION STATEMENT PURSUANT TO RULE 13d-1(k)
The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.
Dated: September 11, 2020
| HEALTHCOR MANAGEMENT, L.P. | |||
| By: | HealthCor Associates, LLC, its general partner | ||
| /s/ Anabelle P. Gray | |||
| Name: | Anabelle P. Gray | ||
| Title: | General Counsel | ||
| HEALTHCOR OFFSHORE GP, LLC, for itself and as general partner of behalf of HEALTHCOR OFFSHORE MASTER FUND, L.P. | |||
| By: | HealthCor Group, LLC, its general partner | ||
| /s/ Anabelle P. Gray | |||
| Name: | Anabelle P. Gray | ||
| Title: | General Counsel | ||
| HEALTHCOR OFFSHORE II GP, LLC, for itself and as general partner of behalf of HEALTHCOR SANATATE OFFSHORE MASTER FUND, L.P. | |||
| By: | HealthCor Group, LLC, its general partner | ||
| /s/ Anabelle P. Gray | |||
| Name: | Anabelle P. Gray | ||
| Title: | General Counsel | ||
| HEALTHCOR THERAPEUTICS GP, LLC, for itself and as general partner of behalf of HEALTHCOR THERAPEUTICS MASTER FUND, L.P. | |||
| By: | HealthCor Group, LLC, its general partner | ||
| /s/ Anabelle P. Gray | |||
| Name: | Anabelle P. Gray | ||
| Title: | General Counsel | ||
| HEALTHCOR ASSOCIATES, LLC | |||
| /s/ Anabelle P. Gray | |||
| Name: | Anabelle P. Gray | ||
| Title: | General Counsel | ||
| HEALTHCOR GROUP, LLC | |||
| /s/ Anabelle P. Gray | |||
| Name: | Anabelle P. Gray | ||
| Title: | General Counsel | ||
| JOSEPH HEALEY, Individually | |||
| /s/ Joseph Healey | |||
| ARTHUR COHEN, Individually | |||
| /s/ Arthur Cohen | |||